Yifan Lu, Lijuan Nie More...
Endocrine, Metabolic & Immune Disorders - Drug Targets[1871-5303], Published 2025,
2023影響因子: 2.0
2.Harnessing phytochemicals: Innovative strategies to enhance cancer immunotherapy
Zhu, Qianru, Zhang, More...
Drug Resistance Updates[1368-7646], Published 2025, Volume 79,
收錄情况: SCOPUS
2023影響因子: 15.8
Zhang, AJ, Luo, XX, More...
FRONTIERS IN PUBLIC HEALTH[2296-2565], Published 2024, Volume 12,
收錄情况: WOS SCOPUS
WOS核心合集引用: 0 2023影響因子: 3.0
Zhu, QR, Zhang, RN, More...
THERANOSTICS[1838-7640], Published 2024, Volume 14, Issue 14, Pages 5443-5460
收錄情况: WOS SCOPUS
WOS核心合集引用: 0 2023影響因子: 12.4
5.Deciphering the role of miRNA-134 in the pathophysiology of depression: A comprehensive review
Wang, Yunkai, Huang, More...
Heliyon[2405-8440], Published 2024, Volume 10, Issue 19,
收錄情况: SCOPUS
2023影響因子: 3.4
6.菟丝子乙醇提取物灌胃对大鼠绝经后骨质疏松症的改善作用及其机制
孟卓然,赵梓铭,贾壮壮,刘韦兵,谭丽萍, More...
山东医药[1002-266X], Published 2024, Volume 64, Issue 17, Pages 29-32
收錄情况: CNKI
Xu, C, Jiang, ZB, Sh More...
PHARMACOLOGICAL RESEARCH[1043-6618], Published 2023, Volume 191,
收錄情况: WOS SCOPUS
WOS核心合集引用: 42 2023影響因子: 9.1 发表年影響因子: 9.1
8.Anoikis-Associated Lung Cancer Metastasis: Mechanisms and Therapies
Wang, J, Luo, ZJ, Li More...
CANCERS[2072-6694], Published 2022, Volume 14, Issue 19,
收錄情况: WOS SCOPUS
WOS核心合集引用: 55 2023影響因子: 4.5 发表年影響因子: 5.2
9.Curcumenol triggered ferroptosis in lung cancer cells via lncRNA H19/miR-19b-3p/FTH1 axis
Zhang, RN, Pan, T, X More...
BIOACTIVE MATERIALS[2452-199X], Published 2022, Volume 13, Pages 23-36
收錄情况: WOS SCOPUS
WOS核心合集引用: 138 2023影響因子: 18.0 发表年影響因子: 18.9
10.Update of Indoles: Promising molecules for ameliorating metabolic diseases
Hu, W, Yan, GY, Ding More...
BIOMEDICINE & PHARMACOTHERAPY[0753-3322], Published 2022, Volume 150,
收錄情况: WOS SCOPUS
WOS核心合集引用: 21 2023影響因子: 6.9 发表年影響因子: 7.5
本系統需要使用 Internet Explorer 9.0 以上Firefox || Chrome瀏覽器
Copyright © 2018 澳門科技大學學者庫